Jul 13, 2020, 03:32 AM by Rebecca Flower

NIBC and the Offeror have reached conditional agreement on an amended recommended all-cash public offer for all issued and outstanding shares in the capital of NIBC.

Jul 9, 2020, 15:40 PM by David Vitek

Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences V (“BXLS V”), the inaugural Blackstone fund in Life Sciences. BXLS V was oversubscribed and closed at its hard cap of $4.6 billion of total capital commitments — the largest life sciences private fund raised to date.

Jul 1, 2020, 16:17 PM by David Vitek

Blackstone (NYSE:BX) announced today that it will host its second quarter investor conference call via public webcast on July 23, 2020 at 9:00 a.m. ET.

Jun 29, 2020, 09:01 AM by Serena Bancroft

Hudson Pacific Properties, Inc. (“Hudson Pacific”) (NYSE: HPP) and Blackstone (NYSE: BX) today announced that funds affiliated with Blackstone Property Partners will acquire a 49% interest in Hudson Pacific’s three Hollywood studios and five on-lot or adjacent Class A office properties, totaling 2.2 million square feet, at a gross portfolio valuation of $1.65 billion.

Jun 25, 2020, 08:13 AM by Emma Quigley

Ruth Porat, Alphabet and Google CFO, Joins Blackstone’s Board of Directors

Jun 23, 2020, 01:04 AM by Alexandra Ritterman

London, June 23 2020 - Blackstone (NYSE:BX) today announced the appointment of Dr. Ulrich Spiesshofer, former President and Chief Executive Officer of ABB Ltd, as Senior Advisor.

Jun 12, 2020, 17:33 PM by David Vitek

Medtronic plc (NYSE:MDT) and Blackstone (NYSE:BX) today announced that Medtronic intends to significantly increase research and development (R&D) funding in its Diabetes Group through an agreement to receive $337 million of funding from funds managed by Blackstone Life Sciences (“BXLS”) including co-investors, aimed at advancing new, innovative products especially designed to reduce the burden of diabetes management.

Jun 11, 2020, 07:36 AM by David Vitek

Blackstone (NYSE: BX) and Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata”), a clinical-stage biopharmaceutical company, today announced that funds managed by Blackstone Life Sciences (“BXLS”) will lead a $350 million royalty and equity investment in Reata to fund the development and potential commercialization of bardoxolone methyl (“bardoxolone”), an investigational once-daily oral therapy being studied for chronic kidney disease (“CKD”) in Alport syndrome, autosomal dominant polycystic kidney disease (“ADPKD”), and other associated potential future indications.

Jun 8, 2020, 02:02 AM by Rebecca Flower

Jun 5, 2020, 08:24 AM by David Vitek

Blackstone Singapore announced today a donation of nearly $600,000 to Community Chest, the fundraising and engagement arm of the National Council of Social Service. The contribution will provide assistance for vulnerable members of the community impacted by the COVID-19 outbreak and includes funding from Blackstone Singapore, its employees and the Blackstone Charitable Foundation.

May 29, 2020, 11:56 AM by Serena Bancroft

Blackstone (NYSE:BX) today announced the appointment of Dr. Mark McClellan (MD, PhD), a physician and economist who served as both the commissioner of the U.S. Food and Drug Administration (FDA) and administrator of the Centers for Medicare & Medicaid Services (CMS), as a Senior Advisor.

May 28, 2020, 09:04 AM by Serena Bancroft

Blackstone (NYSE:BX) announced today that Jon Gray, President & Chief Operating Officer, is scheduled to present at the Morgan Stanley Virtual US Financials Conference on Wednesday, June 10, 2020 at 12:00 pm ET.

May 18, 2020, 15:38 PM by Rebecca Flower

May 12, 2020, 10:32 AM by David Vitek

Blackstone (NYSE: BX) announced today that Stephen Schwarzman, Chairman, CEO and Co-Founder, is scheduled to present virtually at Bernstein’s 36th Annual Strategic Decisions Conference on Wednesday, May 27, 2020 at 1:30PM ET.

May 5, 2020, 10:28 AM by Serena Bancroft

Blackstone (NYSE: BX) announced that Vini Letteri will join Blackstone Growth (“BXG”), the firm’s recently launched global growth equity investing platform. He will be a Senior Managing Director and brings two decades of experience as a seasoned growth equity investor and operations professional.

Apr 28, 2020, 01:30 AM by Rebecca Flower

Apr 23, 2020, 07:05 AM by Emma Quigley

Blackstone will host its first quarter investor conference call via public webcast on April 23, 2020 at 9:00 a.m. ET.

Apr 13, 2020, 16:19 PM by David Vitek

Blackstone (NYSE:BX) announced today that it will host its first quarter investor conference call via public webcast on April 23, 2020 at 9:00 a.m. EST.

Apr 13, 2020, 07:37 AM by David Vitek

Blackstone and Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, today announced the companies have entered into a broad strategic collaboration under which Blackstone will provide up to $2 billion to support Alnylam’s advancement of innovative RNA interference (RNAi) medicines that have the potential to transform the lives of patients suffering from a range of debilitating diseases.

Apr 9, 2020, 12:56 PM by Serena Bancroft

New York – April 9, 2020, Blackstone (NYSE:BX) announced today that funds managed by Blackstone ("Blackstone") have completed their previously announced acquisition of a majority stake in HealthEdge Software (“HealthEdge”), a leading healthcare technology company that delivers next generation Core Administrative Processing Systems (CAPS) solutions to customers across the healthcare ecosystem.